A clinical trial into treatment for gestational diabetes, involving more than 500 pregnant women, has revealed what the lead academic has described as a significant step forward for women. The research has found benefits for both mothers and their newborn babies, and alleviated concerns over the use of the drug metformin, including less weight gain for mothers; no evidence of increase in preterm birth; and no differences in adverse neonatal outcomes.